Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase Plan

18 Nov 2024 09:22

RNS Number : 6098M
Samsung Electronics Co. Ld
18 November 2024
 

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD), on November 15, 2024, announced that its Board of Directors authorized the following Share Repurchase Plan and Decision on Share Repurchase.

 

Share Repurchase Plan

 

1. Title

Share Repurchase Plan

2. Contents

- Total amount : 10 trillion Korean won

- Method : Installment purchase within a year

- Purpose : To increase shareholders value, etc.

3. Information Release

- Provider : IR Team

- Recipients : Investors, media, etc

- Date of release : November 15, 2024

4. Contact Point

IR Team (Phone: 02-2255-9000)

 

 

 

Decision on Share Repurchase

 

 

1. Number of shares to be repurchased

Common

50,144,628

Other

6,912,036

2. Value of shares to be repurchased(Korean won)

Common

2,682,737,598,000

Other

317,262,452,400

3. Expected Period

Start date

November 18, 2024

End date

February 17, 2025

4. Purpose of repurchase

To increase shareholders value, etc.

5. Method of repurchase

Open market

6. Consignment investment brokers

Samsung Securities Co., Ltd.

Korea Investment & Securities Co, Ltd.

Mirae Asset Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

7. Date of board resolution (confirmation date)

 November 15, 2024

- Attendance of independent directors at the board of directors meeting

Present

6

Absent

0

- Attendance of auditors who are not

 Independent Directors

0

8. Daily order quantity limit

Common

6,525,123

Other

691,203

 

9. Other Information to Consider:

- Shares denoted as Other are preferred shares.

- In Item 2 above, the value of shares to be repurchased is based on the closing price on the

 day of the board resolution (November 15, 2024). The actual amount may change

 depending on future stock price fluctuations.

  KRW 53,500 per common share and KRW 45,900 per preferred share

- In Items 4 and 5 above, all repurchased shares are planned to be cancelled.

- In Item 7 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 8 above is the smaller of: [] and [the larger of and ].

  10% of the number of shares to be repurchased: 5,014,462 common; 691,203 preferred

  25% of average daily transaction volume for one month ending the day before the date of the

board resolution: 6,525,123 common; 406,507 preferred

  1% of total number of issued shares: 59,697,825 common; 8,228,867 preferred

- No shares were repurchased prior to the decision to repurchase shares.

- Limit on the amount of repurchased shares (Korean won)

1. Limits to Dividendable profit under Commercial Act as of end-2023

215,847,546,502,476

2. Amount of repurchased shares since end-2023

0

3. Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2023

2,452,976,485,950

4. The interim dividend amount and related profit reserves decided by the board of directors since end-2023

7,356,460,797,750

Limit on the amount of repurchased shares

(1-2-3-4)

206,038,109,218,776

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKFBBCBDKKDD
Date   Source Headline
29th Aug 20258:57 amRNS2025 Half-year Business Report
31st Jul 20259:49 amRNSReport on Share Disposition Results
31st Jul 20259:48 amRNSTransaction with Affilliate Company
31st Jul 20258:55 amRNSSingle Sale and Supply Contract - Replacement
31st Jul 20257:00 amRNSQuarterly Dividend for Second Quarter 2025
31st Jul 20257:00 amRNS2025 2Q Earnings Release
28th Jul 20259:19 amRNSSingle Sale and Supply Contract
25th Jul 20259:53 amRNSDecision on Share Disposition
8th Jul 20258:11 amRNSDecision on Share Repurchase
8th Jul 20257:15 amRNSNotice of 2Q 2025 Earning Release schedule
8th Jul 20257:09 amRNS2Q 2025 Pre-Earnings Guidance
27th Jun 20258:51 amRNSSustainability Report 2025
30th May 20259:58 amRNSCorporate Governance Report FY2024
30th May 20259:49 amRNS2025 1Q Interim Business Report
28th May 202510:10 amRNSReport on Share Disposition Results
23rd May 20259:36 amRNSDecision on Share Disposition
16th May 20259:34 amRNSReport on Share Repurchase Results
30th Apr 20259:05 amRNS2024 Business Report
30th Apr 20258:45 amRNSCharitable Contribution
30th Apr 20258:42 amRNSTransactions with Affiliated Companies
30th Apr 20257:00 amRNS2025 1Q Earnings Release
30th Apr 20257:00 amRNSQuarterly Dividend for First Quarter 2025
8th Apr 20257:00 amRNSNotice of 1Q 2025 Earning Release schedule
8th Apr 20257:00 amRNS1Q 2025 Pre-Earnings Guidance
26th Mar 20257:00 amRNSNotice on Change of Chief Executive Officer
19th Mar 20258:16 amRNSAppointment of New Chief Executive Officer
19th Mar 20258:11 amRNSResults of the 56th Annual General Meeting
18th Feb 202510:21 amRNSDecision on Share Repurchase
18th Feb 202510:07 amRNSCharitable Contribution
18th Feb 20259:57 amRNSDecision on Cancellation of Shares
18th Feb 20259:14 amRNSReference Material for 2025 AGM
18th Feb 20259:01 amRNS2024 Separate Financial Statements
18th Feb 20258:58 amRNS2024 Consolidated Financial Statements
17th Feb 202512:16 pmRNSReport on Share Repurchase Results
13th Feb 20259:12 amRNSFinal Delisting and Listing of Stocks
13th Feb 20258:42 amRNSAdmission to Trading
10th Feb 202512:05 pmRNSNotice of Approval and Publication of Prospectus
31st Jan 20257:00 amRNS2024 4Q Earning Release
31st Jan 20257:00 amRNSYear-End Dividend for FY2024
31st Jan 20257:00 amRNSAnnouncement of Capex Result for FY2024
8th Jan 20257:00 amRNS4Q 2024 Pre-Earnings Guidance
8th Jan 20257:00 amRNSNotice of 4Q 2024 Earning Release
23rd Dec 20247:00 amRNSInvestment in New Semiconductor Plant in Texas, US
29th Nov 20248:01 amRNSCharitable Contribution
29th Nov 20247:55 amRNS2024 3Q Interim Business Report
29th Nov 20247:41 amRNSTransaction with Affiliate Company
26th Nov 202410:01 amRNSDelisting of GDR from the LuxembourgStockExchange
18th Nov 20249:22 amRNSDecision on Share Repurchase Plan
4th Nov 202410:05 amRNSDelisting Announcement
31st Oct 20249:14 amRNSCharitable Contribution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.